Literature DB >> 12051806

Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7,12-dimethylbenz[a]anthracene-induced ovarian carcinogenesis in rats.

Takuji Tanaka1, Hiroyuki Kohno, Mikio Tanino, Yoshitame Yanaida.   

Abstract

The modifying effects of dietary feeding of estrogenic compounds, 4-nonylphenol (4-NP) and genistein (GS), on 7,12-dimethylbenz[a]anthracene (DMBA)-induced ovarian carcinogenesis were investigated in female Sprague-Dawley rats. We also assessed the effects of test compounds on proliferating cell nuclear antigen (PCNA) index and the expression of estrogen receptor (ER)-alpha and -beta and androgen receptor (AR) in induced neoplasms. Rats were given a single injection of DMBA (0.01 ml of 0.5- DMBA suspended in olive oil) into their left ovary to induce ovarian neoplasms. They also received the experimental diet containing 25 to 250 ppm 4-NP or GS for 50 weeks, starting one week after the dosing of DMBA. DMBA exposure produced ovarian adenocarcinoma with an incidence of 35% at the end of the study (Week 51). Dietary administration of 4-NP or GS caused significant reduction in the incidence of ovarian adenocarcinoma: 86% reduction (P=0.0218) by feeding of 25 or 250 ppm 4-NP and 25 ppm GS, and 100% reduction (P=0.0042) by feeding of 250 ppm GS. The PCNA index in adenocarcinomas was higher than that of surface ovarian epithelium. ER-alpha, beta and AR were expressed in a variable percentage of moderately and poorly differentiated adenocarcinoma cell nuclei, but not in well-differentiated adenocarcinoma cells. These results might suggest that dietary feeding of estrogenic compounds either synthetic (4-NP) or natural (GS) could act as an inhibitor of DMBA-induced rat ovarian carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051806     DOI: 10.1006/eesa.2002.2159

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  7 in total

1.  Anti-anxiety, cognitive, and steroid biosynthetic effects of an isoflavone-based dietary supplement are gonad and sex-dependent in rats.

Authors:  Jonathan Friedman; Cheryl Frye
Journal:  Brain Res       Date:  2010-12-15       Impact factor: 3.252

Review 2.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

3.  Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.

Authors:  P B Hoyer; J R Davis; J B Bedrnicek; S L Marion; P J Christian; J K Barton; M A Brewer
Journal:  Gynecol Oncol       Date:  2009-01-16       Impact factor: 5.482

4.  Phytoestrogen biological actions on Mammalian reproductive system and cancer growth.

Authors:  E Zhao; Qing Mu
Journal:  Sci Pharm       Date:  2010-12-31

Review 5.  Genistein as a Potential Anticancer Agent against Ovarian Cancer.

Authors:  Jung-Yun Lee; Hee Seung Kim; Yong-Sang Song
Journal:  J Tradit Complement Med       Date:  2012-04

Review 6.  Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal models.

Authors:  Seung-Hee Kim; Cho-Won Kim; So-Ye Jeon; Ryeo-Eun Go; Kyung-A Hwang; Kyung-Chul Choi
Journal:  Lab Anim Res       Date:  2014-12-24

7.  The combined effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and the phytoestrogen genistein on steroid hormone secretion, AhR and ERβ expression and the incidence of apoptosis in granulosa cells of medium porcine follicles.

Authors:  Joanna Piasecka-Srader; Agnieszka Sadowska; Anna Nynca; Karina Orlowska; Monika Jablonska; Olga Jablonska; Brian K Petroff; Renata E Ciereszko
Journal:  J Reprod Dev       Date:  2015-11-14       Impact factor: 2.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.